SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia

SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia

Abstract Background Aberrant DNA methylation plays a crucial role in the progression of myeloid neoplasms. Previously, our literature reported that slit guidance ligand 2 (SLIT2) promoter methylation was associated with disease progression and indicated a poor prognosis in patients with myelodysplas...

Full description

Bibliographic Details
Main Authors: De-long Wu, Yun Wang, Ting-juan Zhang, Ming-qiang Chu, Zi-jun Xu, Qian Yuan, Ji-chun Ma, Jiang Lin, Jun Qian, Jing-dong Zhou
Format: Article
Language:English
Published: BMC 2022-11-01
Series:European Journal of Medical Research
Subjects:
SLIT2
Methylation
Expression
Progression
Chronic myeloid leukemia
Online Access:https://doi.org/10.1186/s40001-022-00899-2

Internet

https://doi.org/10.1186/s40001-022-00899-2

Similar Items